Sodium Sulfate

Basic Information

Item Value
DrugBank ID DB09472
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 27

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 dyspepsia KG + DL
2 dry eye syndrome KG + DL
3 stomach disease KG + DL
4 sclerosing cholangitis KG + DL
5 bronchitis KG + DL
6 methemoglobinemia, alpha type KG + DL
7 methemoglobinemia KG + DL
8 methemoglobin reductase deficiency KG + DL
9 postgastrectomy syndrome KG + DL
10 primary hereditary glaucoma KG + DL
11 idiopathic bronchiectasis KG + DL
12 congenital prothrombin deficiency KG + DL
13 open-angle glaucoma KG + DL
14 methemoglobinemia due to deficiency of methemoglobin reductase KG + DL
15 HELIX syndrome KG + DL
16 Alstrom syndrome KG + DL
17 renal tubular acidosis KG + DL
18 anaphylaxis KG + DL
19 peptic ulcer disease KG + DL
20 gastroduodenitis KG + DL
21 Senior-Loken syndrome KG + DL
22 food-dependent exercise-induced anaphylaxis KG + DL
23 acute urate nephropathy KG + DL
24 closed-angle glaucoma KG + DL
25 gastroenteritis KG + DL
26 restless legs syndrome KG + DL
27 congestive heart failure KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.